Statin Use and In‐Hospital Mortality in Diabetics with COVID‐19

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19 pandemic, coronaviruses, and diabetes mellitus

(2020) Ranganath Muniyappa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

COVID-19, ACE2, and the cardiovascular consequences

(2020) Andrew M. South et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

(2020) Xiao-Jing Zhang et al.   Cell Metabolism

IDENTIFICATION OF CENTERS OF EXCELLENCE FOR TAVR: AN ASSESSMENT OF THE CURRENT PARADIGM BASED ON PROCEDURE VOLUMES

(2019) Rohan Khera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Propensity-score matching with competing risks in survival analysis

(2018) Peter C. Austin et al.   STATISTICS IN MEDICINE

Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications

(2015) Kulbhushan Tikoo et al.   BIOCHEMICAL PHARMACOLOGY

Methods for Constructing and Assessing Propensity Scores

(2014) Melissa M. Garrido et al.   HEALTH SERVICES RESEARCH

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET